Your session is about to expire
← Back to Search
Stem Cell Transplant
Cord/Placental Blood Transplant for Leukemia and Lymphoma
Phase 2
Waitlist Available
Research Sponsored by Herbert Irving Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Available donor umbilical cord blood that is mismatched on no more than 2 HLA loci
No serious infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial will see if transplanting blood from the umbilical cord or placenta can help treat cancer or aplastic anemia.
Who is the study for?
This trial is for patients with various blood-related cancers or aplastic anemia who are eligible for a bone marrow transplant but don't have a matching donor. They should be under the equivalent of 60 years old, not pregnant or nursing, free from serious infections, HIV negative, and without severe liver disease or psychiatric conditions that could affect participation.Check my eligibility
What is being tested?
The study is testing if umbilical cord blood and placental blood transplants can replace immune cells destroyed by cancer treatments like chemo or radiation in patients with hematologic cancers or aplastic anemia. It's a Phase II trial to determine the effectiveness of this approach.See study design
What are the potential side effects?
Potential side effects may include reactions to the transplant such as graft-versus-host disease (where transplanted cells attack your body), infection risks due to weakened immunity post-transplant, and complications related to chemotherapy or radiation previously received.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a donor for umbilical cord blood that mostly matches my HLA type.
Select...
I do not have a serious infection.
Select...
I am under 60 years old.
Select...
I am eligible for a bone marrow transplant but don't have a donor.
Select...
My liver is functioning well.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of graft-versus-host disease
Response rate
Survival
+1 moreFind a Location
Who is running the clinical trial?
Herbert Irving Comprehensive Cancer CenterLead Sponsor
33 Previous Clinical Trials
899 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,123 Total Patients Enrolled
David G. Savage, MDStudy ChairHerbert Irving Comprehensive Cancer Center
3 Previous Clinical Trials
130 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I don't have any serious health or mental conditions that would stop me from following the study's requirements.I have been diagnosed with a specific blood disorder or immune system condition.I have a donor for umbilical cord blood that mostly matches my HLA type.I do not have a serious infection.I am under 60 years old.I have a history of cancer.I am eligible for a bone marrow transplant but don't have a donor.My liver is functioning well.I haven't had cancer in the last 5 years, except for skin cancer.I have had a condition where my lymphocytes multiply unusually.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What safety protocols have been set for this procedure?
"Even though the efficacy of this treatment hasn't been tested yet, there is some evidence suggesting its safety. Our team at Power has assigned it a score of 2 out of 3 accordingly."
Answered by AI
Are there still opportunities to participate in this trial?
"The clinicaltrials.gov database suggests that this trial, which was initially posted on January 1st 1997 and last modified in December 2013, is no longer recruiting participants. However, there are still a plethora of other medical trials actively looking for candidates at the moment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger